Kevin Fitzgerald is a Jesuit Priest, and also holds dual doctorates in Molecular Genetics and Bioethics from Georgetown University. He is a Research Associate Professor in the Division of Biochemistry and Pharmacology of the Department of Oncology and the David Lauler Chair for Catholic Health Care Ethics at Georgetown University. He is also a member of the Center for Clinical Bioethics at Georgetown and the Secretary’s Advisory Committee on Genetics, Health, and Society, through the Department of Health and Human Services. Dr. FitzGerald’s research interests focus around mammalian gene regulation, but extend somewhat widely from there. His lab is investigating abnormal gene expression linked to tumorigenesis in the MLL family (particularly MLL2) of genes. They are also looking more broadly at a potentially new level of RNA regulation of gene expression. Finally, his team is involved in a project to better understand the effects of certain natural products on gene regulation, especially with regard to tumorigenesis and inflammation. From this molecular biology base, he is also deeply involved in the ethical and social ramifications of the cutting edge biotechnologies that derive from our increased ability to manipulate gene expression--such as genetic engineering, stem cell research, nuclear transfer research, pharmacogenomics, etc. Dr. FitzGerald is an expert on human cloning, cloning research, ethics of cloning, and genetic testing.